04/21/2013 - 11:23pm

It's official. During its most recent quarterly conference call with analysts, CVS Caremark revealed what many had anticipated: Its acquisition of privately held Brazilian drug store chain Drogaria Onofre was complete.

04/21/2013 - 11:23pm

According to research, ownership of smartphones and tablets in particular have grown rapidly over the past couple of years, and that has created a multi-headed omnichannel hydra of a customer who retailers across all channels are desperately trying to appease.

04/21/2013 - 11:23pm

With the steady accumulation of purchasing power attributed to the Hispanic-American community, marketers more and more are targeting Latinos. DSN called in Reny Diaz, director of client engagement for Nielsen, for additional perspective about the Hispanic-American opportunity.

04/21/2013 - 11:23pm

The Hispanic opportunity represents a "new American reality," noted Roberto Ruiz, SVP strategy and insights for Univision Communications, last month at the Consumer Healthcare Products Association's Annual Executive Conference.

04/21/2013 - 11:23pm

Polaroid unveiled its new concept, Polaroid Fotobar, here, in February, with plans to open at least 10 locations this year.

04/21/2013 - 11:23pm

Hointer, which opened last fall, allows men to buy jeans by combining "online conveniences without the offline B.S." Customers walk in, download an app onto a smartphone or tablet, scan a QR code on the tag and are automatically directed to a dressing room.

04/16/2013 - 11:26am

DSN spoke at length with two Catamaran executives — Albert Thigpen, SVP pharmacy operations and industry relations, and Sumit Dutta, SVP and chief medical officer — about the PBM’s new approach to managed pharmacy care and the changes driving that strategy.

03/08/2013 - 5:18pm

While the Food and Drug Administration released draft guidance on regulations for biosimilars in February 2012, the final regulations have yet to appear. But already, everyone from analysts to trade groups to drug makers is preparing for a time when knock-off versions of biotech drugs will become available.

03/08/2013 - 5:18pm

Much of the policy-making conversation about health care in recent years has sought to highlight anticipated cost savings from technology innovation. Critics say this is an outgrowth of the American "fix-it" mentality. Others say technical solutions have yet to take hold outside of medical accounting applications. But there is general agreement that in the area of technologies to nurture medication adherence, the ground remains fertile.